Malaria Consortium is a British charity that works on preventing, controlling, and treating malaria and other communicable diseases in Africa and Asia.
Its seasonal malaria chemoprevention (SMC) program—one among many programs carried out by this organization—distributes preventive anti-malarial drugs to children under five to reduce incidence during the high transmission season.
Malaria Consortium's SMC program has been a GiveWell top-rated charity since 2016,[1] and its cost-effectiveness is estimated to be in the same range as GiveWell's other priority programs.[2] GiveWell estimates that SMC can protect a child from malaria at a cost of about $7, and that a donation to this program has an average cost-effectiveness of $5,000 per life saved.[3][4][5] (The cost of protecting a child from malaria is much lower than the cost of saving a life because a small fraction of people who receive protection would otherwise have died of malaria, and because of other factors.)[4]
Malaria Consortium is also featured in The Life You Can Save's list of "best charities".[6]
As of August 2022, Malaria Consortium has received over $188 million in funding from Open Philanthropy,[7] and over $3.1 million from Effective Altruism Funds.[8][9]